Primary research consultants at FMI’s healthcare domain project that the global surface plasmon resonance system market is poised to reach a valuation of US$ 1.0 billion by 2024.
The positive trend will endure, with forecasts indicating that the market will escalate to US$ 1.6 billion by 2034. This equates to a moderate CAGR of 5.1% over the forecast period.
| Attributes | Key Insights |
|---|---|
| Surface Plasmon Resonance System Market Estimated Size in 2024 | US$ 1.0 billion |
| Projected Market Value in 2034 | US$ 1.6 billion |
| Value-based CAGR from 2024 to 2034 | 5.1% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market for surface plasmon resonance system advanced at a 5.9% CAGR between 2019 and 2023. The market is slated to rise at a moderate CAGR of 5.1% over the forecast period 2024 to 2034. The market witnessed significant growth during the historical period, attributed to the increasing adoption of biopharmaceutical development.
The growing focus on biologics and biosimilars development boosted the demand for the systems for protein characterization, antibody screening, and quality control in biopharmaceutical manufacturing processes.
The surface plasmon resonance systems found new applications in areas such as environmental monitoring, food safety testing, and clinical diagnostics, driving market diversification and expansion.
The market also experienced consolidation through mergers, acquisitions, and partnerships among key players, which led to increased competition and innovation in the technology and instrumentation.
Looking forward to the forecast period, emerging economies will augment the market prospects. Integration of the systems with big data analytics platforms and artificial intelligence algorithms will enable advanced data analysis, pattern recognition, and predictive modeling,
The trend will enhance the efficiency and accuracy of molecular interaction studies and accelerating drug discovery processes. There will be a growing emphasis on developing miniaturized, portable systems for point of care diagnostics and personalized medicine applications. The factor will cater to the demand for rapid, decentralized testing and tailored therapeutic approaches.
Principal Consultant
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | The United States |
|---|---|
| CAGR through 2034 | 5.5% |
The surface plasmon resonance system market in the United States will expand at a CAGR of 5.5% through 2034. The country has a well established healthcare infrastructure, such as hospitals, clinical laboratories, and research facilities.
They provide a conducive environment for the adoption of SPR technology in clinical diagnostics, drug development, as well as biomedical research. The United States is home to a significant number of pharmaceutical, biotechnology, and academic research institutions engaged in drug discovery, biomolecular research, and biopharmaceutical development.
The robust research and development ecosystem fuels the demand for advanced analytical tools such as systems for studying biomolecular interactions.
| Country | The United Kingdom |
|---|---|
| CAGR through 2034 | 4.3% |
The surface plasmon resonance system market in the United Kingdom to expand at a CAGR of 4.3% through 2034. There is a growing demand for technologies that support drug discovery and development processes, with a robust pharmaceutical industry.
The systems play a vital role in drug screening, lead optimization, and characterization of drug target interactions, contributing to their adoption in pharmaceutical research and development in the country.
The United Kingdom is home to renowned universities, research institutions, and biomedical research centers conducting cutting edge research in areas such as drug discovery, molecular biology, and biophysics. The demand for advanced analytical tools like systems is driven by the need to study biomolecular interactions and accelerate scientific discoveries.
| Country | China |
|---|---|
| CAGR through 2034 | 6.5% |
Surface plasmon resonance system trends in China are taking a turn for the better. A 6.5% CAGR is forecast for the country from 2024 to 2034. China has a growing network of academic research institutions, universities, and research centers engaged in biomedical research, drug discovery, and molecular biology studies.
The demand for advanced analytical tools for studying biomolecular interactions and drug target interactions fuels the adoption of SPR technology in academic research laboratories.
The country is investing in precision medicine initiatives aimed at tailoring medical treatment and healthcare interventions to individual patient characteristics. Surface plasmon resonance systems support precision medicine efforts by enabling the study of personalized biomarkers, therapeutic targets, and drug response profiles, driving market growth in the healthcare sector.
| Country | India |
|---|---|
| CAGR through 2034 | 6.1% |
The surface plasmon resonance system market in India is poised to expand at a CAGR of 6.1% through 2034. High throughput screening technologies are in high demand in India for drug discovery, compound screening, and functional genomics studies.
The systems with high throughput capabilities enable rapid screening of compound libraries, lead identification, and optimization, meeting the needs of pharmaceutical and biotechnology industries.
Biotechnology hubs and innovation clusters are emerging in major Indian cities including Bengaluru, Hyderabad, and Pune, fostering collaboration, technology transfer, and commercialization of biotech products. The concentration of biotechnology companies, research institutes, and academic centers creates opportunities for the adoption of systems in drug discovery, diagnostics, and biomanufacturing.
| Country | Australia and New Zealand |
|---|---|
| CAGR through 2034 | 5.1% |
The surface plasmon resonance system market in Australia and New Zealand will expand at a CAGR of 5.1% through 2034. Collaboration between Australian and New Zealand research institutions, biotechnology companies, and international partners fosters technology exchange, knowledge transfer, and market access for systems.
Strategic partnerships with foreign manufacturers and distributors contribute to market expansion and technology adoption. Australia and New Zealand have well established healthcare systems with a growing emphasis on diagnostics as well as personalized medicine.
The systems are increasingly used in clinical diagnostics for biomarker analysis, infectious disease detection, and therapeutic monitoring, contributing to market growth in the healthcare sector.
The below table highlights how imaging system segment is leading the market in terms of product type, and will account for a CAGR of 56.8% through 2034.
Based on application, the drug discovery segment is gaining heights and will to account for a CAGR of 67.4% through 2034.
| Category | CAGR through 2034 |
|---|---|
| Imaging System | 56.8% |
| Drug Discovery | 67.4% |
Based on product type, the imaging system segment will dominate the surface plasmon resonance system market. Imaging systems integrated with the surface plasmon resonance technology offer real time visualization and monitoring of biomolecular interactions at the sensor surface.
The capability provides researchers with valuable insights into binding kinetics, affinity measurements, and molecular dynamics, boosting the demand for imaging enabled systems.
Imaging systems enhance the sensitivity and detection capability of the surface plasmon resonance platforms by enabling the simultaneous detection of multiple analytes or interaction events across the sensor surface. The multiplexing capability expands the analytical utility of the systems in complex biological samples and high throughput screening applications.
By application, the drug discovery segment will dominate the surface plasmon resonance system market. The surface plasmon resonance technology accelerates the hit identification and lead optimization phases of drug discovery by enabling rapid screening of compound libraries against target proteins or biomolecules.
The high sensitivity and throughput of SPR systems facilitate the identification of lead compounds with favorable binding kinetics, potency, and selectivity. Drug discovery requires efficient and reliable methods for identifying potential drug candidates from large compound libraries.
The systems offer label free, real time analysis of biomolecular interactions, making them valuable tools for screening small molecule compounds, peptides, and biologics in early stage drug discovery.
The surface plasmon resonance system market is characterized by the presence of several established players and emerging companies offering a diverse range of instrumentation, consumables, as well as services.
Company Portfolio
| Attribute | Details |
|---|---|
| Estimated Market Size in 2024 | US$ 1.0 billion |
| Projected Market Valuation in 2034 | US$ 1.6 billion |
| Value-based CAGR 2024 to 2034 | 5.1% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in US$ Billion |
| Key Regions Covered |
|
| Key Market Segments Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
The surface plasmon resonance system market is projected to reach a valuation of US$ 1.0 billion in 2024.
The surface plasmon resonance system industry is set to expand by a CAGR of 5.1% through 2034.
The surface plasmon resonance system market is forecast to reach US$ 1.6 billion by 2034.
China is set to be the top performing market, exhibiting a CAGR of 6.5% through 2034.
Imaging system segment is preferred, and will account for a share of 56.8% in 2024.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2024 to 2034
5.3.1. Imaging System
5.3.2. Sensor System
5.3.3. Reagents
5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034
6.3.1. Drug Discovery
6.3.2. Material Science
6.3.3. Biosensors
6.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis by End User, 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by End User, 2024 to 2034
7.3.1. Academic & Research Institutes
7.3.2. Food & Beverage Industry
7.3.3. Biopharmaceutical Companies
7.3.4. Contract Research Organization (CRO)
7.4. Y-o-Y Growth Trend Analysis by End User, 2019 to 2023
7.5. Absolute $ Opportunity Analysis by End User, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product
14.2.3. By Application
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Application
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2023
16.1.2.1. By Product
16.1.2.2. By Application
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2023
16.2.2.1. By Product
16.2.2.2. By Application
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2023
16.3.2.1. By Product
16.3.2.2. By Application
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2023
16.4.2.1. By Product
16.4.2.2. By Application
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2023
16.5.2.1. By Product
16.5.2.2. By Application
16.5.2.3. By End User
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2023
16.6.2.1. By Product
16.6.2.2. By Application
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2023
16.7.2.1. By Product
16.7.2.2. By Application
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2023
16.8.2.1. By Product
16.8.2.2. By Application
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2023
16.9.2.1. By Product
16.9.2.2. By Application
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2023
16.10.2.1. By Product
16.10.2.2. By Application
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2023
16.11.2.1. By Product
16.11.2.2. By Application
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2023
16.12.2.1. By Product
16.12.2.2. By Application
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2023
16.13.2.1. By Product
16.13.2.2. By Application
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2023
16.14.2.1. By Product
16.14.2.2. By Application
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2023
16.15.2.1. By Product
16.15.2.2. By Application
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2023
16.16.2.1. By Product
16.16.2.2. By Application
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2023
16.17.2.1. By Product
16.17.2.2. By Application
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2023
16.18.2.1. By Product
16.18.2.2. By Application
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2023
16.19.2.1. By Product
16.19.2.2. By Application
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2023
16.20.2.1. By Product
16.20.2.2. By Application
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2023
16.21.2.1. By Product
16.21.2.2. By Application
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2023
16.22.2.1. By Product
16.22.2.2. By Application
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2023
16.23.2.1. By Product
16.23.2.2. By Application
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Bio-Rad Laboratories
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Attana AB
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Nicoya
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. BioNavis Ltd.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Reichert Technologies
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Biosensing Instrument Inc.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. GWC Technologies Inc.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Plexera Bioscience LLC
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Horiba Scientific
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Sensata Technologies
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Carterra, Inc.
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Surface Plasmon Resonance System Market
